ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.827,91
-0,35%
Brent Oil
84,025
0,09%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) Notícias

POLB

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:POLB
DataHoraFonteTítuloCódigoCompanhia
09/05/202403:00RNS Regulatory NewsPoolbeg Pharma PLC Annual Report & AGM NoticeLSE:POLBPoolbeg Pharma Plc
01/05/202412:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202403:00RNS Regulatory NewsPoolbeg Pharma PLC Significant POLB 001 Patent Granted in USALSE:POLBPoolbeg Pharma Plc
30/04/202412:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202403:02RNS Regulatory NewsPoolbeg Pharma PLC Appointment of Joint BrokerLSE:POLBPoolbeg Pharma Plc
30/04/202403:01RNS Regulatory NewsPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug CandidateLSE:POLBPoolbeg Pharma Plc
30/04/202403:00RNS Regulatory NewsPoolbeg Pharma PLC Results for the year ended 31 December 2023LSE:POLBPoolbeg Pharma Plc
29/04/202403:00RNS Regulatory NewsPoolbeg Pharma PLC TR-1: Notification of major holdingsLSE:POLBPoolbeg Pharma Plc
20/03/202413:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202404:00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 US Patent UpdateLSE:POLBPoolbeg Pharma Plc
22/02/202404:00RNS Regulatory NewsPoolbeg Pharma PLC Director/PDMR ShareholdingLSE:POLBPoolbeg Pharma Plc
19/02/202410:42RNS Regulatory NewsPoolbeg Pharma PLC Director Share PurchaseLSE:POLBPoolbeg Pharma Plc
15/02/202413:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202404:00RNS Regulatory NewsPoolbeg Pharma PLC Board Role Change and Launch of EIPLSE:POLBPoolbeg Pharma Plc
12/02/202416:44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202404:00RNS Regulatory NewsPoolbeg Pharma PLC Market Opportunity for POLB 001 for CRSLSE:POLBPoolbeg Pharma Plc
17/01/202410:58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202404:00UK RegulatoryPoolbeg Pharma PLC Further data shows POLB001 potential in cancer CRSLSE:POLBPoolbeg Pharma Plc
20/12/202317:00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202304:00UK RegulatoryPoolbeg Pharma PLC RSV AI Drug Candidate Analysis UpdateLSE:POLBPoolbeg Pharma Plc
11/12/202304:00UK RegulatoryPoolbeg Pharma PLC POLB 001 Data Presented at ASHLSE:POLBPoolbeg Pharma Plc
30/11/202304:00UK RegulatoryPoolbeg Pharma PLC Directorate ChangeLSE:POLBPoolbeg Pharma Plc
21/11/202311:39Alliance NewsAlliance NewsTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo FisherLSE:POLBPoolbeg Pharma Plc
21/11/202304:00RNS Non-RegulatoryPoolbeg Pharma PLC Immunomodulator II patent granted in JapanLSE:POLBPoolbeg Pharma Plc
16/11/202304:00RNS Non-RegulatoryPoolbeg Pharma PLC POLB 001 LPS Trial Data to be Presented at IUISLSE:POLBPoolbeg Pharma Plc
09/11/202313:57Alliance NewsAlliance NewsIN BRIEF: Poolbeg Pharma appoints former Amryt executives to teamLSE:POLBPoolbeg Pharma Plc
09/11/202304:00UK RegulatoryPoolbeg Pharma PLC Former Amryt Pharma Leadership Team join PoolbegLSE:POLBPoolbeg Pharma Plc
03/11/202304:05UK RegulatoryPoolbeg Pharma PLC POLB001 Data to be Presented at ASH Annual MeetingLSE:POLBPoolbeg Pharma Plc
01/11/202304:00UK RegulatoryPoolbeg Pharma PLC POLB 001 Oncology Programme Update MeetingLSE:POLBPoolbeg Pharma Plc
26/10/202303:00RNS Non-RegulatoryPoolbeg Pharma PLC SAB Endorses Influenza Drug TargetsLSE:POLBPoolbeg Pharma Plc
 Apresentando as notícias mais relevantes sobre:LSE:POLB

Seu Histórico Recente

BOV
VVEO3
CM Hospitalar ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
TELB4
TELEBRAS PN
BOV
IBOV
Índice Bovespa
BOV
CASH3
Meliuz S.A ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados